[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613238":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":22,"centralContacts":32,"locations":38,"responsibleParty":57,"collaborators":59,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":64,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":22,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":41,"whyStopped":22,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University Hospital, Ghent","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"Patients with suspicion of a uterine septum on two-dimensional transvaginal ultrasound","EXPERIMENTAL",[12,13,14,15],"Diagnostic Test: Magnetic Resonance Imaging","Diagnostic Test: Three-dimensional transvaginal ultrasound","Diagnostic Test: Three-dimensional transvaginal Gel Infusion Sonography","Other: Questionnaires",[17,23,26,29],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"DIAGNOSTIC_TEST","Magnetic Resonance Imaging","MRI of the pelvis",[9],null,{"type":18,"name":24,"description":24,"armGroupLabels":25,"otherNames":22},"Three-dimensional transvaginal ultrasound",[9],{"type":18,"name":27,"description":27,"armGroupLabels":28,"otherNames":22},"Three-dimensional transvaginal Gel Infusion Sonography",[9],{"type":6,"name":30,"description":30,"armGroupLabels":31,"otherNames":22},"Questionnaires",[9],[33],{"name":34,"role":35,"phone":36,"phoneExt":22,"email":37},"Laura D'hoore, MD","CONTACT","0032 9 332 07 58","septum@uzgent.be",[39],{"facility":40,"status":41,"city":42,"state":22,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Ghent University Hospital","RECRUITING","Ghent","9000","Belgium","BE",{"type":47,"coordinates":48},"Point",[49,50],3.71667,51.05,{"lat":50,"lon":49},[53,54],{"name":34,"role":35,"phone":36,"phoneExt":22,"email":37},{"name":55,"role":56,"phone":22,"phoneExt":22,"email":22},"Tjalina Hamerlynck, MD, PhD","PRINCIPAL_INVESTIGATOR",{"type":58,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR",[60],{"name":61,"class":6},"Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek)","100613238","added-value-of-three-dimensional-transvaginal-ultrasound-3d-tvus-and-gel-infusion-sonography-3d-gis-compared-with-magnetic-resonance-imaging-mri-in-the-diagnosis-of-patients-with-suspicion-of-a-uterine-septum-100613238",false,"NCT07263984","Added Value of Three-dimensional Transvaginal Ultrasound (3D TVUS) and Gel Infusion Sonography (3D GIS) Compared With Magnetic Resonance Imaging (MRI) in the Diagnosis of Patients With Suspicion of a Uterine Septum.","SEPTUM-D Project: Diagnosis in Patients With a Uterine Septum","SEPTUM-D","Inclusion Criteria:\n\n* Women aged between 18 and 45 years\n* With suspicion of a uterine septum on routine 2D TVUS\n* Who are willing to give informed consent\n\nExclusion Criteria:\n\n* Women aged below 18 years and over 45 years\n* Prior definitive diagnosis of a uterine septum or other congenital uterine anomaly\n* Prior surgery in relation to a uterine septum\n* Cervical (unilateral) aplasia\n* Vaginal aplasia\n* Untreated obstructive vaginal septum\n* Any co-morbidity that is found to interfere with the uterine measurements required in the study\n* Contraindications for MRI\n* Not willing or not possible to undergo transvaginal ultrasound\n* Pregnancy at the time of inclusion\n* Wish to conceive between inclusion and last diagnostic intervention\n* Visual or pathological evidence of cervical, uterine or ovarian malignancy\n* Patients with an intrauterine device (by mistake), who are not willing to remove this device before the start of the diagnostic interventions","FEMALE","18 Years","45 Years",{"count":74,"type":75},145,"ESTIMATED","INTERVENTIONAL",[78],"NA","The goal of this clinical trial is to investigate the added value of three-dimensional transvaginal ultrasound (3D TVUS) and gel infusion sonography (3D GIS) for diagnosing a partition in the uterus (uterine septum) in comparison to magnetic resonance imaging (MRI). The main question it aims to answer is:\n\nHow well do 3D TVUS and 3D GIS detect a uterine septum compared to MRI?\n\nParticipants will receive 3D TVUS\u002F 3D GIS and MRI, and will complete questionnaires.",[81],"Uterine Septum",[83,84,24,19,85],"Uterine septum","Diagnosis","Gel Infusion Sonography","2025-12-01",{"date":88,"type":89},"2025-12-04","ACTUAL",{"date":91,"type":89},"2025-10-27",{"date":93,"type":75},"2028-10",{"name":5,"class":6},1]